Recurrence: all 3,523 studies
Page 3 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for Relapsed/Refractory B-cell MalignanciesRecruitingNCT07345728Not applicable
- huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular LymphomaRecruitingNCT07343934Phase 1
- ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLLRecruitingNCT07342478Phase 3
- Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell TherapyRecruitingNCT07341191Phase 2
- Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor TherapyRecruitingNCT07340164Phase 2
- CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune DiseasesRecruitingNCT07337785Early Phase 1
- Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence FactorsRecruitingNCT07337460Phase 2
- Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence FactorsRecruitingNCT07337421Phase 2
- Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority StudyNot yet recruitingNCT07331805Not applicable
- Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid TumorNot yet recruitingNCT07331064Phase 1
- Clinical Study of LV009 Injection in the Treatment of Recurrent/Refractory CD19 Positive Blood TumorsNot yet recruitingNCT07330895Early Phase 1
- Neurobiological and Genomic Predictors of Relapse in DepressionRecruitingNCT07328373
- An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic AnemiaNot yet recruitingNCT07324889Phase 1/2
- Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune DiseasesRecruitingNCT07322718Early Phase 1
- Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCTNot yet recruitingNCT07319793Not applicable
- A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell LymphomasNot yet recruitingNCT07316920Phase 1
- A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic MalignanciesNot yet recruitingNCT07316907Phase 1
- A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple MyelomaRecruitingNCT07312188Phase 2
- IASO208 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesRecruitingNCT07309900Phase 1
- A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)RecruitingNCT07306832Phase 1
- Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)RecruitingNCT07297979Phase 1
- Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of IndiaRecruitingNCT07290972
- Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral HerniasNot yet recruitingNCT07289490Not applicable
- Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)Not yet recruitingNCT07288814Phase 1/2
- Vitamin D for Preventing Recurrent Preeclampsia in Pregnant WomenRecruitingNCT07288801Phase 4
- Transition to KPL-387 Monotherapy Dosing & Administration StudyRecruitingNCT07288216Phase 2
- The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic AnemiaRecruitingNCT07287228Phase 1/2
- Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian CancerNot yet recruitingNCT07286162Phase 3
- MRgFUS for Parkinson's TremorRecruitingNCT07284719Not applicable
- A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma SubjectsRecruitingNCT07280013Phase 1
- 125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant TumorsNot yet recruitingNCT07277777Phase 2
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruitingNCT07277413Phase 1
- AI Wound Alert & Home Management for Recurrent DFUNot yet recruitingNCT07277010
- BY002 IIT Study in R/R Acute LeukemiaRecruitingNCT07270770Phase 1
- Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 TrialRecruitingNCT07263438Phase 2
- A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.RecruitingNCT07258979Phase 1/2
- CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and LymphomaRecruitingNCT07257419Phase 1
- Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell LymphomaRecruitingNCT07254754Phase 2
- Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis MarkersRecruitingNCT07243015
- Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyRecruitingNCT07242963
- Early Recurrence After Surgery for Pancreatic CancerEnrolling by invitationNCT07241676
- An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Refractory Immune-mediated Kidney DiseaseRecruitingNCT07241468Early Phase 1
- Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell MalignanciesRecruitingNCT07240974Early Phase 1
- Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical StudyRecruitingNCT07236203
- SL4903 CAR-T Therapy for Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07234721Early Phase 1
- CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological TumorsRecruitingNCT07234110Not applicable
- A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MSNot yet recruitingNCT07222956Phase 2
- A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)RecruitingNCT07221253Phase 3
- A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial CancerRecruitingNCT07209449Phase 2
- A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])RecruitingNCT07208058Phase 3
- Penfluridol for Relapsed/Refractory Small Cell CancersNot yet recruitingNCT07206563Phase 1/2
- A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell NeoplasmsNot yet recruitingNCT07200479Phase 1
- Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNPNot yet recruitingNCT07200336Phase 4
- Six Versus Twelve Month Index Follow-up After Large Colon Polyp ResectionEnrolling by invitationNCT07198945Not applicable
- Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized TrialNot yet recruitingNCT07198451Phase 2/3
- Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell LymphomaRecruitingNCT07198230
- Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCCRecruitingNCT07197580Phase 3
- Evaluation of the Impact of Pilonidal Cyst Recurrence on Quality of Life in Patients Previously Treated With Conventional Surgery or Laser TherapyRecruitingNCT07194161
- A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple SclerosisRecruitingNCT07189325Phase 3
- Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent CystitisRecruitingNCT07186465Phase 4
- HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesNot yet recruitingNCT07175415Phase 1/2
- Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary DiseaseRecruitingNCT07174076Phase 4
- A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic MalignanciesRecruitingNCT07173595Phase 1
- CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell LymphomasEnrolling by invitationNCT07168486Phase 1
- xDRIVE for Florida-based Cancer PatientsRecruitingNCT07167381Not applicable
- Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)Not yet recruitingNCT07166549Phase 1
- Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial CancerRecruitingNCT07166094Phase 3
- Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell LymphomaRecruitingNCT07164560Phase 1
- Vyxeos® With Clofarabine for Pediatric AMLRecruitingNCT07156435Phase 1
- A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT07138209Phase 3
- HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid LeukemiaRecruitingNCT07137637Phase 1
- A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)RecruitingNCT07137494Phase 1
- A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function RecoveryNot yet recruitingNCT07136987Phase 3
- Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal MelanomaRecruitingNCT07136181Phase 1/2
- Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell LymphomaRecruitingNCT07126236Phase 2
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune DiseasesRecruitingNCT07123519Phase 1
- A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaRecruitingNCT07123454Phase 1/2
- Pirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell LymphomaNot yet recruitingNCT07122609Phase 2
- A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT07116616Phase 1/2
- NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's LymphomaRecruitingNCT07114367Phase 1
- Iadademstat + SBRT With Atezo in ES-SCLCRecruitingNCT07113691Phase 1
- RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic MalignanciesNot yet recruitingNCT07113496Phase 1
- SVC-isolation in Redo-AF Ablation With Isolated PVNot yet recruitingNCT07112716Not applicable
- A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic MalignanciesNot yet recruitingNCT07107204Phase 1/2
- Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic LeukemiaRecruitingNCT07105579Phase 2
- A Study of Teclistamab and Mezigdomide in People With Multiple MyelomaRecruitingNCT07105059Phase 1
- A Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07104721Phase 1
- IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)RecruitingNCT07104032Phase 3
- Acupuncture Combined With Chemotherapy for Gastric Cancer After SurgeryNot yet recruitingNCT07098949Not applicable
- Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033Not yet recruitingNCT07097948Phase 2
- A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory NeuroblastomaRecruitingNCT07085338Phase 2
- TLN-121 in Relapsed or Refractory Non-Hodgkin LymphomasRecruitingNCT07082803Phase 1
- A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)RecruitingNCT07082686Phase 2
- Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic AnemiaNot yet recruitingNCT07078721Phase 2
- Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver ResectionNot yet recruitingNCT07077798Not applicable
- CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell NeoplasmsNot yet recruitingNCT07077330Early Phase 1
- RN1201 Injection in the Treatment of Antibody-Mediated DiseasesRecruitingNCT07072247Phase 1
- Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II TrialRecruitingNCT07070479Phase 2
- A Study of CTD402 in T-ALL/LBL PatientsRecruitingNCT07070219Phase 1/2
- A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.RecruitingNCT07062965Phase 3